All In Biotech

Drug Trial Radar · NCT00125905

ISTAPS: A Stepped Primary Care Smoking Cessation Intervention

Effectiveness of a Stepped Primary Care Smoking Cessation Intervention Based on an Evidence Based Clinical Practice Guideline (ISTAPS Project)

Last checked: Nov 19, 2026Latest source record: Sep 30, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 3,012 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

3,012

Actual

Start

Oct 2003

Primary completion

Not stated

Study completion Jul 2006

Sponsor

Sponsor type
Academic, hospital or other
Collaborators
Preventive Services and Health Promotion Research Network
First posted
Aug 2, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 14 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary care centers can play a very important role in helping people to stop smoking. There is a large body of research on the effectiveness of specific interventions especially addressed to people who want to stop smoking. In addition to that, there are no studies with a large sample of individuals included that tested the complete range of interventions recommended nowadays for helping people in the different smoking cessation stages of change and with different degrees of physical and psychological dependence, especially including motivational interviewing in those not interested in cessation in the very next weeks. This study will test a complex intervention that at first classifies smokers in stages and after that treats every smoker according to what stage he/she is in at the moment, his/her degree of dependence and his/her own characteristics.

Conditions

  • Smoking Cessation

Interventions

  • AdviceBehavioral

  • Motivational InterviewingBehavioral

  • Nicotine Gum and PatchDrug

  • BupropionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Self reported abstinence confirmed by an expired air carbon monoxide concentration of 10 parts per millions or less
  2. Point prevalence at the end of intervention, 1 and 2 years after the beginning of intervention
  3. Continuous abstinence rate for 1 year
  4. Change of stage in the smoking cessation process

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Jordi Gol i Gurina Foundation-Primary Care Research Institute

    Barcelona, Barcelona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.